M&T Bank’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$406K Buy
5,412
+878
+19% +$56.4K ﹤0.01% 1306
2026
Q1
$255K Sell
4,534
-1,620
-26% -$106K ﹤0.01% 1448
2025
Q4
$494K Buy
6,154
+1,457
+31% +$97.9K ﹤0.01% 1133
2025
Q3
$229K Buy
4,697
+2,016
+75% +$125K ﹤0.01% 1333
2025
Q2
$200K Sell
2,681
-1,131
-30% -$74.9K ﹤0.01% 1443
2025
Q1
$243K Buy
+3,812
New +$259K ﹤0.01% 1336
2021
Q2
Sell
-2,010
Closed -$222K 1602
2021
Q1
$222K Sell
2,010
-1,788
-47% -$221K ﹤0.01% 1371
2020
Q4
$451K Buy
3,798
+721
+23% +$77.6K ﹤0.01% 1111
2020
Q3
$268K Buy
+3,077
New +$269K ﹤0.01% 1292
2020
Q2
Sell
-3,367
Closed -$335K 1626
2020
Q1
$335K Sell
3,367
-865
-20% -$93.8K ﹤0.01% 1060
2019
Q4
$487K Buy
4,232
+103
+2% +$12.5K ﹤0.01% 861
2019
Q3
$521K Buy
4,129
+625
+18% +$79.3K ﹤0.01% 949
2019
Q2
$422K Buy
+3,504
New +$345K ﹤0.01% 1059
2015
Q4
Sell
-14,810
Closed -$478K 1797
2015
Q3
$478K Sell
14,810
-22,194
-60% -$835K ﹤0.01% 1080
2015
Q2
$1.53M Sell
37,004
-10,170
-22% -$429K 0.01% 717
2015
Q1
$2.12M Sell
47,174
-7,408
-14% -$310K 0.01% 601
2014
Q4
$2.04M Sell
54,582
-630
-1% -$23.1K 0.01% 603
2014
Q3
$1.93M Buy
55,212
+29,032
+111% +$1.04M 0.01% 624
2014
Q2
$924K Hold
26,180
0.04% 310
2014
Q1
$853K Hold
26,180
0.04% 305
2013
Q4
$1.1M Buy
+26,180
New +$1.08M 0.05% 255

Other funds holding HAE

M&T Bank's HAE Position: Q2 2026 in Review

M&T Bank increased its Haemonetics (HAE) stake by 19% in Q2 2026, buying an estimated $56.4K and bringing the position to 5,412 shares worth $406K. The position accounts for ﹤0.01% of the portfolio, ranked #1306.

M&T Bank first reported a position in HAE in Q4 2013 and has held it in 21 quarters since. The position peaked at $2.12M in Q1 2015. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • M&T Bank held 5,412 shares of Haemonetics worth $406K as of Q2 2026.
  • M&T Bank bought 878 Haemonetics shares in Q2 2026, an estimated $56.4K.
  • Haemonetics made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #1306 holding.
  • M&T Bank first reported a position in Haemonetics in Q4 2013 and has held it in 21 quarters since.
  • M&T Bank's Haemonetics position peaked at $2.12M in Q1 2015.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.